Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Surgical oncology
- Publicado em
- 10 out 2023
- Citações
- 17
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
Ali Alqahtani, Abdurahman Alloghbi, Philip Coffin, Chao Yin, Reetu Mukherji, Benjamin A Weinberg
Descritores MeSH
- Circulating Tumor DNA
- Pancreatic Neoplasms
- Carcinoma, Pancreatic Ductal
- Proto-Oncogene Proteins p21(ras)
- Prognosis
- Biomarkers, Tumor
- Humans
- Mutation
Veja também
Estudos relacionados
- Prognostic value of KRAS gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
- Prognostic role and clinicopathological features of SMAD4 gene mutation in pancreatic cancer: a systematic review and meta-analysis
- Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis
- Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal Cancer